NanoViricides, Inc. NNVC
1.44
0.00
0.00%
as of 25 Sep
- Market cap
- $38.0M
- P/E
- 0.0×
Follow NNVC
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(99.75%) | (94.03%) | (77.53%) | (89.97%) | |
| (87.47%) | (80.86%) | (69.79%) | (79.91%) | ||
ROIC |
(100.60%) | (84.94%) | (88.61%) | (86.02%) | |
Return on Tangible Assets |
(131.52%) | (118.48%) | (77.33%) | (91.51%) | |
Free Cash Flow per Share |
(0.56) | (0.44) | (0.37) | (0.34) | |
Free Cash Flow |
(8.54) | (7.57) | (7.43) | (7.37) | |
Capital Expenditures |
(0.06) | (0.09) | (0.09) | (0.09) | |
| Other line items | |||||
Cash ROIC |
(93.42%) | (90.09%) | (45.22%) | (58.83%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.90 | 0.92 | 0.88 | 0.90 | |
Depreciation/Fixed assets |
0.11 | 0.10 | 0.09 | 0.09 | |
Capex/Depreciation |
(0.08) | (0.14) | (0.15) | (0.17) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.56) | (0.44) | (0.37) | (0.34) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates